Inhibition of epidermal growth factor receptor-associated tyrosine kinase blocks glioblastoma invasion of the brain

Neurosurgery

Volumn 40, Issue 1, 1997, Pages 141-151

  Penar, Paul L ^a   Khoshyomn, Sami ^a   Bhushan, Alok ^a   Tritton, Thomas R ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

Epidermal growth factor receptor; Genistein; Glioblastoma; Tyrosine kinase

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE; GENISTEIN; PROTEIN TYROSINE KINASE; TYRPHOSTIN;

ANIMAL TISSUE; ARTICLE; BINDING SITE; CANCER INFILTRATION; CANCER INVASION; CANCER MORTALITY; EXTRACELLULAR MATRIX; GLIOBLASTOMA; GROWTH INHIBITION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; RECEPTOR BINDING; TUMOR GROWTH;

ANIMALS; BRAIN; BRAIN NEOPLASMS; CELL DIVISION; CELL MOVEMENT; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GENISTEIN; GLIOBLASTOMA; HUMANS; ISOFLAVONES; MICROSCOPY, CONFOCAL; NEOPLASM INVASIVENESS; NITRILES; PROTEIN-TYROSINE KINASES; RATS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SPHEROIDS, CELLULAR; TYRPHOSTINS;

EID: 0031016446     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-199701000-00032     Document Type: Article

References (86)

1. Aaronson SA: Growth factors and cancer. Science 254:1146-1153, 1991.
2. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M, Fukami Y: Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 262:5592-5595, 1987.
3. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM, McEwan RN: A rapid in vitro assay for quantitating the invasive potential of tumour cells. Cancer Res 47:3239-3245, 1987.
4. Barnes S: Effect of genistein on in vitro and in vivo models of cancer. J Nutr 125[Suppl 3]:777S-783S, 1995.
5. Barnes S, Grubbs C, Setchell KD, Carlson J: Soybeans inhibit mammary tumors in models of breast cancer. Prog Clin Biol Res 347:239-253, 1990.
6. Barrandon Y, Green H: Cell migration is essential for sustained growth of keratinocyte colonies: The roles of transforming growth factor-alpha and epidermal growth factor. Cell 50:1131-1137, 1987.
7. Berdel WE, de Vos S, Maurer J, Oberberg D, von Marschall Z, Schroeder JK, Li J, Ludwig W-D, Kreuser ED, Thiel E, Herrmann F: Recombinant human stem cell factor stimulates growth of a human glioblastoma cell line expressing c-kit protooncogene. Cancer Res 52:3498-3502, 1992.
8. Bjerkvig R: Reaggregation of fetal rat brain cells in a stationary culture system: II - Ultrastructural characterization. In Vitro Cell Dev Biol 22:193-200, 1986.
9. Bjerkvig R, Steinsvåg SK, Laerum OD: Reaggregation of fetal rat brain cells in a stationary culture system: I - Methodology and cell identification. In Vitro Cell Dev Biol 22:180-192, 1986.
10. Bjerkvig R, Tonnesen A, Laerum OD, Backlund EO: Multicellular tumor spheroids from human gliomas maintained in organ culture. J Neurosurg 72:463-475, 1990.
11. Blay J, Brown KD: Epidermal growth factor promotes the chemotactic migration of cultured rat intestinal epithelial cells. J Cell Physiol 124:107-112, 1985.
12. Brady LW, Miyamoto C, Woo DV, Rackover M, Emrich J, Bender H, Dadparvar S, Steplewski Z, Koprowski H, Black P, Lazzaro B, Nair S, McCormack T, Nieves J, Morabito M, Eshleman J: Malignant astrocytomas treated with iodine-125 labeled monoclonal antibody 425 against epidermal growth factor receptor: A phase II trial. Int J Radiat Oncol Biol Phys 22:225-230, 1992.
13. Chaffanet M, Chauvin C, Lainé M, Berger F, Chedin M, Rost N, Nissou MF, Benabid AL: EGF receptor amplification and expression in human brain tumours. Eur J Cancer 28:11-17, 1992.
14. Chen P, Gupta K, Wells A: Cell movement elicited by epidermal growth factor receptor requires kinase and autophosphorylation but is separable from mitogenesis. J Cell Biol 124:547-555, 1994.
15. Chen P, Xie H, Sekar MC, Gupta K, Wells A: Epidermal growth factor receptor-mediated cell motility: Phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movement. J Cell Biol 127:847-857, 1994.
16. Ciardiello F, Damiano V, Bianco C, di Isernia G, Ruggiero A, Caraglia M, Tagliaferri P, Baselga J, Mendelsohn J, Bianco AR, Tortora G: Cooperative antiproliferative effects of 8-chloro-cyclic AMP and 528 anti-epidermal growth factor receptor monoclonal antibody on human cancer cells. Clin Cancer Res 1:161-167, 1995.
17. Daviet I, Herbert JM, Maffrand JP: Involvement of protein kinase C in the mitogenic and chemotaxis effects of basic fibroblast growth factor on bovine cerebral cortex capillary endothelial cells. FEBS Lett 259:315-317, 1990.
18. Devaux BC, O'Fallon JR, Kelly PJ: Resection, biopsy, and survival in malignant glial neoplasms. J Neurosurg 78:767-775, 1993.
19. Di Carlo A, Mariano A, Macchia PE, Moroni MC, Beguinot L, Macchia V: Epidermal growth factor receptor in human brain tumors. J Endocrinol Invest 15:31-37, 1992.
20. Edvardsen K, Pedersen P-H, Bjerkvig R, Hermann GG, Zeuthen J, Laerum OD, Walsh FS, Bock E: Transfection of glioma cells with the neural-cell adhesion molecule NCAM: Effect on glioma-cell invasion and growth in vivo. Int J Cancer 58:116-122, 1994.
21. Ekstrand AJ, Longo N, Hamid ML, Olson JJ, Liu L, Collins VP, James CD: Functional characterization of an EGF receptor with a truncated extracellular domain expressed in glioblastomas with EGFR gene amplification. Oncogene 9:2313-2320, 1994.
22. Ekstrand AJ, Sugawa N, James CD, Collins VP: Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N- and/or C-terminal tails. Proc Natl Acad Sci U S A 89: 4309-4313, 1992.
23. Engebraaten O, Bjerkvig R, Berens ME: Effect of alkyllysophospholipid on glioblastoma cell invasion into fetal rat brain tissue in vitro. Cancer Res 51:1713-1719, 1991.
24. Engebraaten O, Bjerkvig R, Lund-Johansen M, Wester K, Pedersen P-H, Mork S, Backlund E-O, Laerum OD: Interaction between human brain tumour biopsies and fetal rat brain tissue in vitro. Acta Neuropathol 81:130-140, 1990.
25. Engebraaten O, Bjerkvig R, Pedersen PH, Laerum OD: Effects of EGF, bFGF, NGF and PDGF(bb) on cell proliferative, migratory and invasive capacities of human brain-tumour biopsies in vitro. Int J Cancer 53:209-214, 1993.
26. Feinstein DL, Galea E, Cermak J, Chugh P, Lyandvert L, Reis DJ: Nitric oxide synthase expression in glial cells: Suppression by tyrosine kinase inhibitors. J Neurochem 62:811-814, 1994.
27. Fotsis T, Pepper M, Adlercreutz H, Fleischmann G, Hase T, Montesano R, Schweigerer L: Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc Natl Acad Sci U S A 90:2690-2694, 1993.
28. Fuller GN, Bigner SH: Amplified cellular oncogenes in neoplasms of the human central nervous system. Mutat Res 276:299-306, 1992.
29. Gately S, Tsanaclis AM, Takano S, Klasgsbrun M, Brem S: Cells transfected with the basic fibroblast growth factor gene fused to a signal sequence are invasive in vitro and in situ in the brain. Neurosurgery 36:780-788, 1995.
30. Gill GN, Kawamoto T, Cochet C, Le A, Sato JD, Masui H, McLeod C, Mendelsohn J: Monoclonal anti-epidermal growth factor receptor antibodies which are inhibitors of epidermal growth factor binding and antagonists of epidermal growth factor-stimulated tyrosine protein kinase activity. J Biol Chem 259: 7755-7760, 1984.
31. Glenney J Jr, Zokas L, Kamps MP: Monoclonal antibodies to phosphotyrosine. J Immunol Methods 109:277-285, 1988.
32. Harris AL, Nicholson S, Sainsbury R, Wright C, Farndon J: Epidermal growth factor receptor and other oncogenes as prognostic markers. Monogr Natl Cancer Inst 11:181-187, 1992.
33. Hermanson M, Funa K, Hartman-M, Claesson-Welsh L, Heldin CH, Westermark B, Nister M: Platelet-derived growth factor and its receptors in human glioma tissue: Expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. Cancer Res 52:3213-3219, 1992.
34. Hiesiger EM, Hayes RL, Pierz DM, Budzilovich GN: Prognostic relevance of epidermal growth factor receptor (EGF-R) and c-neu/erbB2 expression in glioblastomas (GBMs). J Neurooncol 16:93-104, 1993.
35. Humphrey PA, Wong AJ, Vogelstein B, Zalutsky MR, Fuller GN, Archer GE, Friedman HS, Kwatra MM, Bigner SH, Bigner DD: Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma. Proc Natl Acad Sci U S A 87:4207-4211, 1990.
36. Hunter T: The epidermal growth factor receptor gene and its product. Nature 311:414-416, 1984.
37. Hurtt MR, Moossy J, Donovan-Peluso M, Locker J: Amplification of epidermal growth factor receptor gene in gliomas: Histopathology and prognosis. J Neuropathol Exp Neurol 51:84-90, 1992.
38. Kelsey KT, Nagasawa H, Umans RS, Little JB: Epidermal growth factor induces cytogenetic damage in mammalian cells. Carcinogenesis 8:625-627, 1987.
39. Khazaie K, Schirrmacher V, Lichtner RB: EGF receptor in neoplasia and metastasis. Cancer Metastasis Rev 12:255-274, 1993.
40. Khoshyomn S, Penar PL, McBride WJ, Taatjes DJ: Four-dimensional analysis of human brain tumor spheroid invasion into fetal rat brain aggregates using confocal scanning laser microscopy. J Neurooncol (in press).
41. Klemke RL, Yebra EM, Bayna EM, Cheresh DA: Receptor tyrosine kinase signaling required for integrin alpha v beta 5-directed cell motility but not adhesion to vitronectin. J Cell Biol 127:859-866, 1994.
42. Koochekpour S, Merzak A, Pilkington GJ: Extracellular matrix proteins inhibit proliferation, upregulate migration and induce morphological changes in human glioma lines. Eur J Cancer 31A:375-380, 1995.
43. Kreth FW, Warnke PC, Scheremet R, Ostertag CB: Surgical resection and radiation therapy versus biopsy and radiation therapy in the treatment of glioblastoma multiforme. J Neurosurg 78:762-766, 1993.
44. Levitzki A: Tyrphostins: Potential antiproliferative agents and novel molecular tools. Biochem Pharmacol 40:913-918, 1990.
45. Lund-Johansen M: Interactions between human glioma cells and fetal rat brain aggregates studied in a chemically defined medium. Invasion Metastasis 10:113-128, 1990.
46. Lund-Johansen M, Bjerkvig R, Humphrey PA, Bigner SH, Bigner DD, Laerum OD: Effect of epidermal growth factor on glioma cell growth, migration, and invasion in vitro. Cancer Res 50:6039-6044, 1990.
47. Lund-Johansen M, Forsberg K, Bjerkvig R, Laerum OD: Effects of growth factors on a human glioma cell line during invasion into rat brain aggregates in culture. Acta Neuropathol 84:190-197, 1992.
48. Lyall RM, Zilberstein A, Gazit A, Gilon C, Levitzki A, Schlessinger J: Tyrphostins inhibit epidermal growth factor (EGF)-receptor tyrosine kinase activity in living cells and EGF-stimulated cell proliferation. J Biol Chem 264:14503-14509, 1989.
49. +)-ATPase by insulin/insulin-like growth factor I in cultured rat astrocytes. Arch Biochem Biophys 307:175-182, 1993.
50. Matsumo B: Cell Biological Applications of Confocal Microscopy. San Diego, Academic Press, Inc., 1993.
51. Merzak A, Koocheckpour S, Pilkington GJ: CD44 mediates human glioma cell adhesion and invasion in vitro. Cancer Res 54:3988-3992, 1994.
52. Merzak A, Koocheckpour S, Pilkington GJ: Cell surface gangliosides are involved in the control of human glioma cell invasion in vitro. Neurosci Lett 177:44-46, 1994.
53. Miyaji K, Tani E, Shindo H, Nakano A, Tokunaga T: Effect of tyrphostin on cell growth and tyrosine kinase activity of epidermal growth factor receptor in human gliomas. J Neurosurg 81: 411-419, 1994.
54. Morrison RS, Giordano S, Yamaguchi F, Hendrickson S, Berger MS, Palczewski K: Basic fibroblast growth factor expression is required for clonogenic growth of human glioma cells. J Neurosci Res 34:502-509, 1993.
55. Murano M, Kovach JS, Kelly PJ, Yanagihara T: Transforming growth factor-alpha, epidermal growth factor receptor, and proliferating potential in benign and malignant gliomas. J Neurosurg 75:97-102, 1991.
56. Murphy PA: Phytoestrogen content of processed soybean products. Food Technol 36:62-64, 1982.
57. Naganuma H, Sasaki A, Nukui H, Tasaka K: Antiproliferative cytokines secreted by lymphokine-activated killer cells stimulated with tumor cells. J Neurosurg 77:411-416, 1992.
58. O'Dell TJ, Kandel ER, Grant SGN: Long-term potentiation in the hippocampus is blocked by tyrosine kinase inhibitors. Nature 353:558-560, 1991.
59. Okabe M, Uehara Y, Noshima T, Itaya T, Kunieda Y, Kurosawa M: In vivo antitumor activity of herbimycin A, a tyrosine kinase inhibitor, targeted against BCR/ABL oncoprotein in Mice BCR/ ABL-transfected cells. Leuk Res 18:867-873, 1994.
60. Panayotou G, Waterfield MD: The assembly of signalling complexes by receptor tyrosine kinases. Bioessays 15:171-177, 1993.
61. Parmar VS, Jain R, Sharma SK, Vardhan A, Jha A, Taneja P, Singh S, Vyncke BM, Bracke ME, Mareel MM: Anti-invasive activity of 3,7-dimethoxyflavone in vitro. J Pharm Sci 83:1217-1221, 1994.
62. Pedersen PH, Ness GO, Engebraaten O, Bjerkvig R, Lillehaug JR, Laerum OD: Heterogeneous response to the growth factors [EGF, PDGF(bb), TGF-a, bFGF, IL-2] on glioma spheroid growth, migration and invasion. Int J Cancer 56:255-261, 1994.
63. Peterson G: Evaluation of the biochemical targets of genistein in tumor cells. J Nutr 125[Suppl 3]:784S-789S, 1995.
64. Peterson G, Barnes S: Genistein inhibition of the growth of human breast cancer cells: Independence from estrogen receptors and the multi-drug resistance gene. Biochem Biophys Res Commun 179: 661-667, 1991.
65. Phillips PC, Levow C, Catterall M, Colvin OM, Pastan I, Brem H: Transforming growth factor-alpha-Pseudomonas exotoxin fusion protein (TGF-alpha-PE38) treatment of subcutaneous and intracranial human glioma and medulloblastoma xenografts in athymic mice. Cancer Res 54:1008-1015, 1994.
66. Quigley MR, Maroon JC: The relationship between survival and the extent of the resection in patients with supratentorial malignant gliomas. Neurosurgery 29:385-389, 1991.
67. Redekop GJ, Naus CC: Transfection with bFGF sense and anti-sense cDNA resulting in modification of malignant glioma growth. J Neurosurg 82:83-90, 1995.
68. Reifenberger G, Prior R, Deckert M, Wechsler W: Epidermal growth factor receptor expression and growth fraction in human tumours of the nervous system. Virchows Arch A Pathol Anat 414:147-155, 1989.
69. Reynolds FH Jr, Todaro GJ, Fryling C, Stephenson JR: Human transforming growth factors induce tyrosine phosphorylation of EGF receptors. Nature 292:259-262, 1981.
70. Rheinwald JG, Green H: Epidermal growth factor and the multiplication of cultured human epidermal keratinocytes. Nature 265: 421-424, 1977.
71. Salcman M: Epidemiology and factors affecting survival, in Apuzzo MLJ (ed): Malignant Cerebral Glioma. Park Ridge, AANS, 1990, pp 95-109.
72. Schlegel J, Merdes A, Stumm G, Albert FK, Forsting M, Hynes N, Kiessling M: Amplification of the epidermal-growth-factor-receptor gene correlates with different growth behaviour in human glioblastoma. Int J Cancer 56:72-77, 1994.
73. Schlessinger J: How receptor tyrosine kinases activate ras. Trends Biochem Sci 18:273-275, 1993.
74. Schlessinger J, Ullrich A: Growth factor signaling by receptor tyrosine kinases. Neuron 9:383-391, 1992.
75. Smith GJ, Bagnell CR, Bakewell WE, Black KA, Bouldin TW, Earnhardt TS, Hook GER, Pryzwansky KB: Application of confocal scanning laser microscopy in experimental pathology. J Electron Microsc Tech 18:38-49, 1991.
76. Stoscheck C, King LE Jr: Role of epidermal growth factor in carcinogenesis. Cancer Res 46:1030-1037, 1986.
77. Terzis AJA, Fiskerstrand T, Refsum H, Ueland PM, Arnold H, Bjerkvig R: Proliferation, migration and invasion of human glioma cells exposed to antifolate drugs. Int J Cancer 54:112-118, 1993.
78. Torp SH, Helseth E, Dalen A, Unsgaard G: Relationships between Ki-67 labelling index, amplification of the epidermal growth factor receptor gene, and prognosis in human glioblastomas. Acta Neurochir Wien 117:182-186, 1992.
79. Tuzi NL, Venter DJ, Kumar S, Staddon SL, Lemoine NR, Gullick WJ: Expression of growth factor receptors in human brain tumours. Br J Cancer 63:227-233, 1991.
80. U H-S, Espiritu OD, Kelley PY, Klauber MR, Hatton JD: The role of the epidermal growth factor receptor in human gliomas: I - The control of cell growth. J Neurosurg 82:841-846, 1995.
81. Uckun FM, Evans WE, Forsyth CJ, Waddick KG, Ahlgren LT, Chelstorm LM, Burkhardt A, Bolen J, Meyrs DE: Biotherapy of B-cell precursor leukemia by targeting genistein to CD19-associated tyrosine kinase. Science 267:886-891, 1995.
82. Ushiro H, Cohen S: Identification of phosphotyrosine as a product of epidermal growth factor-activated protein kinase in A-431 cell membranes. J Biol Chem 255:8363-8365, 1980.
83. Westermark B, Magnusson A, Heldin CH: Effect of epidermal growth factor on membrane motility and cell locomotion in cultures of human clonal glioma cells. J Neurosci Res 8:491-507, 1982.
84. Xie H, Turner T, Wang M-H, Singh RK, Siegal GP, Wells A: In vitro invasiveness of DU-145 human prostate carcinoma cells is modulated by EGF receptor-mediated signals. Clin Exp Metastasis 13:407-419, 1995.
85. Xu X, Wang H, Murphy PA, Cook L, Hendrich S: Diadzein is a more bioavailable soymilk isoflavone than is genistein in adult women. J Nutr 124:825-832, 1994.
86. Yang LJ, Rhee SG, Williamson JR: Epidermal growth factor-induced activation and translocation of phospholipase C-gamma 1 to the cytoskeleton in rat hepatocytes. J Biol Chem 269:7156-7162, 1994.